M. Johnston

HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer

G. Tiao, L. Timchenko, N. Timchenko, 2021, Cellular and molecular gastroenterology and hepatology.

Incidence and management of pleural effusions in patients with Wilms tumor: A Pediatric Surgical Oncology Research Collaborative study

Hau D. Le, D. Rothstein, B. Naik-Mathuria, 2022, International journal of cancer.

β‐catenin cancer–enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma

M. Weirauch, Je-Hyun Yoon, G. Tiao, 2022, Hepatology communications.

Molecular signatures of aggressive pediatric liver cancer

N. Timchenko, M. Johnston, 2021, Archives of stem cell and therapy.

Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient‐Derived Xenograft Models

M. Weirauch, S. Cairo, G. Tiao, 2021, Hepatology.

Natural Course of Pediatric Portal Hypertension

Alexander R. Cortez, G. Tiao, T. Jenkins, 2020, Hepatology communications.

Hepatoblastomas exhibit marked NNMT downregulation driven by promoter DNA hypermethylation

P. Pearson, M. Maschietto, D. Carraro, 2020, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin

N. Timchenko, J. Geller, M. Johnston, 2021, Frontiers in Pharmacology.